B
Bernard Masquelier
Researcher at University of Bordeaux
Publications - 112
Citations - 4960
Bernard Masquelier is an academic researcher from University of Bordeaux. The author has contributed to research in topics: Viral load & Drug resistance. The author has an hindex of 40, co-authored 112 publications receiving 4824 citations. Previous affiliations of Bernard Masquelier include Centre national de la recherche scientifique & Centre Hospitalier Universitaire de Bordeaux.
Papers
More filters
Journal ArticleDOI
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
Linda Wittkop,Huldrych F. Günthard,Frank de Wolf,David Dunn,Alessandro Cozzi-Lepri,Alessandro Cozzi-Lepri,Andrea De Luca,Andrea De Luca,Claudia Kücherer,Niels Obel,Viktor von Wyl,Bernard Masquelier,Christoph Stephan,Carlo Torti,Andrea Antinori,Federico García,Ali Judd,Kholoud Porter,Rodolphe Thiébaut,Hannah Castro,Ard van Sighem,Céline Colin,Jesper Kjaer,Jens D Lundgren,Roger Paredes,Anton Pozniak,Bonaventura Clotet,Andrew N. Phillips,Deenan Pillay,Geneviève Chêne +29 more
TL;DR: Findings confirm present treatment guidelines for HIV, which state that the initial treatment choice should be based on resistance testing in treatment-naive patients, that the effect of TDR on outcome in the first year of cART is confirmed.
Journal ArticleDOI
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis
Jonathan Z. Li,Roger Paredes,Heather J. Ribaudo,Evguenia S. Svarovskaia,Karin J. Metzner,Michael J. Kozal,Katherine Huppler Hullsiek,Melanie Balduin,Martin R. Jakobsen,Anna Maria Geretti,Rodolphe Thiébaut,Lars Østergaard,Bernard Masquelier,Jeffrey A. Johnson,Michael D. Miller,Daniel R. Kuritzkes +15 more
TL;DR: In a pooled analysis, low-frequency HIV-1 drug resistance mutations, particularly involving NNRTI resistance, were significantly associated with a dose-dependent increased risk of virologic failure with first-line ART.
Journal ArticleDOI
Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis
Elise Arrivé,Marie-Louise Newell,Didier K. Ekouevi,Marie-Laure Chaix,Rodolphe Thiébaut,Bernard Masquelier,Valériane Leroy,Philippe Van de Perre,Christine Rouzioux,François Dabis +9 more
TL;DR: This systematic review and meta-analysis of summarized data aimed to estimate the proportion of mothers and children with NVP resistance mutations detected in plasma samples 4-8 weeks postpartum after single-dose NVP use for PMTCT.
Journal ArticleDOI
European guidelines on the clinical management of HIV-1 tropism testing
Linos Vandekerckhove,Annemarie M. J. Wensing,Rolf Kaiser,Françoise Brun-Vézinet,Bonaventura Clotet,A. De Luca,A. De Luca,S. Dressler,Federico García,Anna Maria Geretti,Thomas Klimkait,Klaus Korn,Bernard Masquelier,Carlo Federico Perno,Jonathan M. Schapiro,Vincent Soriano,Anders Sönnerborg,Anne-Mieke Vandamme,Chris Verhofstede,Hauke Walter,Maurizio Zazzi,Charles A. Boucher +21 more
TL;DR: The European Consensus Group on clinical management of tropism testing was established to make recommendations to clinicians and clinical virologists recommended an enhanced sensitivity Trofile assay and V3 population genotyping are the recommended methods.
Journal ArticleDOI
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease
Marie-Jeanne Mayaux,Marianne Burgard,Jean-Paul Teglas,Cottalorda J,Krivine A,François Simon,J. Puel,Catherine Tamalet,Dormont D,Bernard Masquelier,Doussin A,Christine Rouzioux,Stéphane Blanche +12 more
TL;DR: These prognostic markers, particularly virological parameters, are of value in monitoring children infected by HIV and might serve as a basis for early therapeutic intervention in children born to infected mothers.